On January 7, 2026, China’s National Medical Products Administration (“NMPA”) released an Announcement on Further Optimizing the Review and Approval of Drugs Marketed Overseas That Are Urgently Needed in Clinical…
The Latest
Subscribe to Covington Blogs
A weekly digest of featured articles










